BIOSPECIFICS TECHNOLOGIES CORP
10QSB, EX-27, 2000-06-15
PHARMACEUTICAL PREPARATIONS
Previous: BIOSPECIFICS TECHNOLOGIES CORP, 10QSB, 2000-06-15
Next: ECO SOIL SYSTEMS INC, DEFA14A, 2000-06-15



<TABLE> <S> <C>


<ARTICLE>                     5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                       Jan-31-2001
<PERIOD-START>                          Feb-01-1999
<PERIOD-END>                            Apr-30-2000
<CASH>                                    4,894,691
<SECURITIES>                              1,046,955
<RECEIVABLES>                               975,618
<ALLOWANCES>                                      0
<INVENTORY>                               1,948,321
<CURRENT-ASSETS>                            256,271
<PP&E>                                    3,324,132
<DEPRECIATION>                            1,445,874
<TOTAL-ASSETS>                           11,891,861
<CURRENT-LIABILITIES>                             0
<BONDS>                                           0
                             0
                                       0
<COMMON>                                      4,891
<OTHER-SE>                                        0
<TOTAL-LIABILITY-AND-EQUITY>                      0
<SALES>                                   1,439,003
<TOTAL-REVENUES>                          1,439,003
<CGS>                                       479,787
<TOTAL-COSTS>                               479,787
<OTHER-EXPENSES>                            411,679
<LOSS-PROVISION>                                  0
<INTEREST-EXPENSE>                            1,583
<INCOME-PRETAX>                             (62,888)
<INCOME-TAX>                                 (3,030)
<INCOME-CONTINUING>                         (65,918)
<DISCONTINUED>                                    0
<EXTRAORDINARY>                                   0
<CHANGES>                                         0
<NET-INCOME>                                      0
<EPS-BASIC>                                   (0.01)
<EPS-DILUTED>                                 (0.01)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission